These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3338231)

  • 41. [Psilocybine poisoning resulting from eating mushrooms].
    Stienstra R; van Poorten JF; Vermaas FA; Rupreht J
    Ned Tijdschr Geneeskd; 1981 May; 125(21):833-5. PubMed ID: 7242738
    [No Abstract]   [Full Text] [Related]  

  • 42. No clinically relevant effects in children after accidental ingestion of Panaeolina foenisecii (lawn mower's mushroom).
    Schenk-Jaeger KM; Hofer-Lentner KE; Plenert B; Eckart D; Haberl B; Schulze G; Borchert-Avalone J; Stedtler U; Pfab R
    Clin Toxicol (Phila); 2017 Mar; 55(3):217-220. PubMed ID: 28073319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mushroom poisoning epidemiology in the United States.
    Brandenburg WE; Ward KJ
    Mycologia; 2018; 110(4):637-641. PubMed ID: 30062915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The determination of psilocin and psilocybin in hallucinogenic mushrooms by HPLC utilizing a dual reagent acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection system.
    Anastos N; Lewis SW; Barnett NW; Sims DN
    J Forensic Sci; 2006 Jan; 51(1):45-51. PubMed ID: 16423222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
    Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L
    J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poisoning by hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes K. Yokoyama) indigenous to Japan.
    Musha M; Ishii A; Tanaka F; Kusano G
    Tohoku J Exp Med; 1986 Jan; 148(1):73-8. PubMed ID: 3705065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The psychology of hallucinogenic drug discontinuers.
    Salzman C; Lieff J; Kochansky GE; Shader RI
    Am J Psychiatry; 1972 Dec; 129(6):755-61. PubMed ID: 4404760
    [No Abstract]   [Full Text] [Related]  

  • 48. Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.
    Strauss D; Ghosh S; Murray Z; Gryzenhout M
    3 Biotech; 2022 Dec; 12(12):339. PubMed ID: 36340802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The hallucinogens and the inhalants.
    Cohen S
    Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.
    Baker RW; Chothia C; Pauling P; Weber HP
    Mol Pharmacol; 1973 Jan; 9(1):23-32. PubMed ID: 4685449
    [No Abstract]   [Full Text] [Related]  

  • 51. [Narcotic dependence problems studied at the Poison Center in Wroclaw].
    Antończyk A
    Przegl Lek; 1997; 54(6):466-9. PubMed ID: 9333904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Harm potential of magic mushroom use: a review.
    van Amsterdam J; Opperhuizen A; van den Brink W
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):423-9. PubMed ID: 21256914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug abuse in Slovak Republic.
    Kresanek J; Plackova S; Caganova B; Klobusicka Z
    Przegl Lek; 2005; 62(6):357-60. PubMed ID: 16225068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The occurrence of psilocybin in Gymnopilus species.
    Hatfield GM; Valdes LJ
    Lloydia; 1978; 41(2):140-4. PubMed ID: 565861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal failure after eating "magic" mushrooms.
    Raff E; Halloran PF; Kjellstrand CM
    CMAJ; 1992 Nov; 147(9):1339-41. PubMed ID: 1302482
    [No Abstract]   [Full Text] [Related]  

  • 56. [COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].
    KANDIC B; DORDEVIC D
    Vojnosanit Pregl; 1963 May; 20():275-9. PubMed ID: 14067329
    [No Abstract]   [Full Text] [Related]  

  • 57. Mushroom poisoning in Hong Kong: a ten-year review.
    Chan CK; Lam HC; Chiu SW; Tse ML; Lau FL
    Hong Kong Med J; 2016 Apr; 22(2):124-30. PubMed ID: 26980450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography.
    Sottolano SM; Lurie IS
    J Forensic Sci; 1983 Oct; 28(4):929-35. PubMed ID: 6685168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning].
    Musha M; Kusano G; Tanaka F; Gotoh Y; Ishii A
    Seishin Shinkeigaku Zasshi; 1988; 90(4):313-33. PubMed ID: 3413259
    [No Abstract]   [Full Text] [Related]  

  • 60. Between prohibitions: patterns and meanings of magic mushroom use in the UK.
    Riley SC; Blackman G
    Subst Use Misuse; 2008; 43(1):55-71. PubMed ID: 18189205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.